Novo Nordisk A/S (NVO)
48.79
+2.43
(+5.24%)
USD |
NYSE |
Dec 10, 14:42
Novo Nordisk EPS Diluted (Quarterly): 0.7044 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Evaxion AS | -0.2862 |
| Ascendis Pharma A/S | -1.173 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Omeros Corp. | -0.4666 |
| Viking Therapeutics, Inc. | -0.8083 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.132B |
| Revenue (Quarterly) | 11.74B |
| Total Expenses (Quarterly) | 8.607B |
| Enterprise Value | 216.80B |
| Gross Profit Margin (Quarterly) | 76.12% |
| Profit Margin (Quarterly) | 26.68% |
| Earnings Yield | 7.04% |
| Operating Earnings Yield | 9.11% |
| Normalized Earnings Yield | 7.036 |